Raising the Tone: Lessons from the Past

By now you’ve probably heard of the ongoing saga at Valeant (VRX). The beleaguered pharmaceutical company has seen its stock plummet, questions about its accounting practices, harsh criticisms about its business practices, and turmoil among management and the board. A recent … Continue reading

2014 SEC Filing Highlights, Part 1 of 2

In this post we kick off what we hope will be an annual series. It is a full-year recap of some of the most notable SEC disclosures that we track: a “best-of-the-year” review. In this first post, we’ll look at the largest restatement; the … Continue reading

PCAOB Member Discusses Trends in Internal Control Audits

This past Saturday, PCAOB Board Member Jeanette M. Franzel presented a speech at the AAA Annual Meeting on current issues and trends in the audits of internal controls over financial reporting (ICFR). Relying significantly on data from Audit Analytics, Franzel’s speech discussed the impact … Continue reading

CEO and CFO Departures: A Ten Year Review

In response to Section 409 of the Sarbanes-Oxley Act related to “Real Time Issuer Disclosures,” the SEC began requiring all 10-K filers to disclose within four business days any personnel changes affecting the company’s directors and officers. This disclosure requirement became effective on … Continue reading